Serum proteins involved in decay and regeneration of cobra venom factor-dependent complement activation
Fearon, D.T.; Austen, K.F.; Ruddy, S.
Journal of Immunology 111(6): 1730-1736
1973
ISSN/ISBN: 0022-1767 PMID: 4796101 Document Number: 64638
Document emailed within 1 workday
Related Documents
Hoopes, P.C.; McCall, C.E. 1977: The effect or cobra venom factor (CVJ) activation of the complement cascade on leukocyte circadian variation in the rat Experientia 33(2): 224-226Seelig, R.; Seelig, H.P. 1975: The possible role of serum complement system in the formal pathogenesis of acute pancreatitis II. Cobra venom factor pancreatitis--sodiumtaurocholate and deoxycholate pancreatitis Acta Hepato-Gastroenterologica 22(5): 335-346
Pang, A.S.; Minta, J.O. 1980: Inhibition of vitamin D2-induced arteriosclerosis in rats by depletion of complement with cobra venom factor Artery 7(2): 109-122
Quigg, R.J.; Nicholson-Weller, A.; Cybulsky, A.V.; Badalamenti, J.; Salant, D.J. 1989: Decay accelerating factor regulates complement activation on glomerular epithelial cells Journal of Immunology 142(3): 877-882
Shibata, T.; Cosio, F.G.; Birmingham, D.J. 1991: Complement activation induces the expression of decay-accelerating factor on human mesangial cells Journal of Immunology 147(11): 3901-3908
Hancock, W.W.; Blakely, M.L.; Van der Werf, W.; Bach, F.H. 1993: Rejection of guinea pig cardiac xenografts post-cobra venom factor therapy is associated with infiltration by mononuclear cells secreting interferon-gamma and diffuse endothelial activation Transplantation Proceedings 25(5): 2932
Shiau Lin, S.Y.; Su, S.C.; Lee, C.Y. 1976: Comparative studies on cytotoxin from the Indian cobra venom and cardiotoxin from the Formosan cobra venom, with special reference to the effect on the growth of Ehrlich ascites tumor cells in mice Journal of the Formosan Medical Association 75(6): 328-336
Cary, N.; Moody, J.; Yannoutsos, N.; Wallwork, J.; White, D. 1993: Tissue expression of human decay accelerating factor, a regulator of complement activation expressed in mice: a potential approach to inhibition of hyperacute xenograft rejection Transplantation Proceedings 25(1 Pt 1): 400-401
Mold, C.; Gewurz, H. 1980: Activation of human complement by liposomes: serum factor requirement for alternative pathway activation Journal of Immunology 125(2): 696-700
Peng, M.H.; Meng, K.W.; Yang, D.H. 2001: The effect of Chinese cobra venom factor on guinea pig to rat cardiac xenotransplantation Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 15(4): 240-243
Shobonov, B.B.; Kozlov, L.V.; Antonov, V.K. 1989: Complement-inhibiting acidic factors from the venom of Central Asian cobra Naja naja oxiana Biokhimiia 54(12): 2054-2060
Martinelli, G.P.; Matsuda, T.; Waks, H.S.; Osler, A.G. 1978: Studies on immunosuppression by cobra venom factor. III. on early responses to sheep erythrocytes in C5-deficient mice Journal of Immunology 121(5): 2052-2055
Kemp, E.; Steinbrüchel, D.; Starklint, H.; Larsen, S.; Henriksen, I.; Dieperink, H. 1987: Renal xenograft rejection: prolonging effect of captopril, ACE-inhibitors, prostacyclin, and cobra venom factor Transplantation Proceedings 19(6): 4471-4474
Rauterberg, E.W.; Ritz, E. 1988: Bioincompatibility of dialysis membranes: factor H binding correlates inversely with complement activation indicating a local imbalance of involved proteases/anti-proteases Advances in Experimental Medicine and Biology 240: 365-375
Li, Z-dong.; Shi, C-qing.; Zhang, Q-hua.; Xiong, Y-liang.; Zhou, X-ding.; Wang, W-yu.; Song, N. 2004: Mechanisms of purified cobra venom factor in preventing hyperacute rejection following discordant liver xenotransplantation in rats Zhonghua Yi Xue Za Zhi 84(23): 2007-2010
Kobayashi, T.; Taniguchi, S.; Ye, Y.; Niekrasz, M.; Kosanke, S.; Neethling, F.A.; Wright, L.J.; Rose, A.G.; White, D.J.; Cooper, D.K. 1996: Delayed xenograft rejection in C3-depleted discordant (pig-to-baboon) cardiac xenografts treated with cobra venom factor Transplantation Proceedings 28(2): 560
Tseng, C.T.; Springgate, C.F.; Tadmori, W.; Choi, Y.S. 1988: Identification of a novel human B cell activation antigen involved in B cell growth factor-dependent proliferation Journal of Immunology 140(7): 2305-2311
Baker, J.; Martin, M.; Ye, Y.; Oleinick, S.; Zuhdi, N.; Cooper, D.K. 1992: Presence of a complement-dependent "cytotoxic factor" in dog serum: relevance to experimental discordant xenotransplantation Transplantation Proceedings 24(2): 490-491
Kurpiewski, G.; Campbell, B.J.; Forrester, L.J.; Barrett, J.T. 1981: Alternate complement pathway activation by recluse spider venom International Journal of Tissue Reactions 3(1): 39-45
Iwata, K.; Seya, T.; Ariga, H.; Nagasawa, S. 1994: Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein Journal of Immunology 152(7): 3436-3444